JP2008512497A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008512497A5 JP2008512497A5 JP2007531441A JP2007531441A JP2008512497A5 JP 2008512497 A5 JP2008512497 A5 JP 2008512497A5 JP 2007531441 A JP2007531441 A JP 2007531441A JP 2007531441 A JP2007531441 A JP 2007531441A JP 2008512497 A5 JP2008512497 A5 JP 2008512497A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbon atoms
- proliferative skin
- formula
- psoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 [*+]C(C1)(*2(N)OC1[n]1c(cccc3)c3c3c1C1N2c2ccccc2C1C(CN1)=C3C1=O)O Chemical compound [*+]C(C1)(*2(N)OC1[n]1c(cccc3)c3c3c1C1N2c2ccccc2C1C(CN1)=C3C1=O)O 0.000 description 14
- BTRYFUFLLBZPIG-CACGZCQESA-N C=Cc1c(C=C)[n](C(C[C@]2(C#N)O)O[C@@]22C#C)c3c4[n]2c2ccccc2c4c(CNC2=O)c2c13 Chemical compound C=Cc1c(C=C)[n](C(C[C@]2(C#N)O)O[C@@]22C#C)c3c4[n]2c2ccccc2c4c(CNC2=O)c2c13 BTRYFUFLLBZPIG-CACGZCQESA-N 0.000 description 1
- KIIMUGXXJSGBIE-OVGGWZFISA-N CC(C)[C@@](C)(C1)[C@]2(C#C)OC1[n]1c3c4[n]2c(cccc2)c2c4c(CNC2=O)c2c3c2c1cccc2 Chemical compound CC(C)[C@@](C)(C1)[C@]2(C#C)OC1[n]1c3c4[n]2c(cccc2)c2c4c(CNC2=O)c2c3c2c1cccc2 KIIMUGXXJSGBIE-OVGGWZFISA-N 0.000 description 1
- VRISOVIJHUWTGL-AQBRBNKESA-N CC([C@]1(C2(CC2)O[C@@H](C[n]2c3c4[nH]c5ccccc5c4c(CNC4=O)c4c3c3c2cccc3)C1)[O]#C)NC Chemical compound CC([C@]1(C2(CC2)O[C@@H](C[n]2c3c4[nH]c5ccccc5c4c(CNC4=O)c4c3c3c2cccc3)C1)[O]#C)NC VRISOVIJHUWTGL-AQBRBNKESA-N 0.000 description 1
- UIARLYUEJFELEN-UHFFFAOYSA-N CC1(C(CO)(C2)O)OC2[n]2c3c4[n]1c(cccc1)c1c4c(CNC1=O)c1c3c1c2cccc1 Chemical compound CC1(C(CO)(C2)O)OC2[n]2c3c4[n]1c(cccc1)c1c4c(CNC1=O)c1c3c1c2cccc1 UIARLYUEJFELEN-UHFFFAOYSA-N 0.000 description 1
- JTEJPVOMSDLCGF-COTLDPOVSA-N CCOC(C[C@]1(CN)O)[n](c2c3cccc2)c2c3c(C(NC3)=O)c3c3c2[n]1c1ccccc31 Chemical compound CCOC(C[C@]1(CN)O)[n](c2c3cccc2)c2c3c(C(NC3)=O)c3c3c2[n]1c1ccccc31 JTEJPVOMSDLCGF-COTLDPOVSA-N 0.000 description 1
- WPYIOIATWMPYPM-NKQHSMGESA-N C[C@@]1([C@@](C2)(C(C)=O)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2ccc(Br)c1 Chemical compound C[C@@]1([C@@](C2)(C(C)=O)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2ccc(Br)c1 WPYIOIATWMPYPM-NKQHSMGESA-N 0.000 description 1
- DBEXFMRWDMXGRZ-XINCGQIGSA-N C[C@@]1([C@@](C2)(C=O)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CN(C1=O)N)c1c3c1c2cccc1 Chemical compound C[C@@]1([C@@](C2)(C=O)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CN(C1=O)N)c1c3c1c2cccc1 DBEXFMRWDMXGRZ-XINCGQIGSA-N 0.000 description 1
- BDHDDBGWWKEZPZ-GSIQFNFPSA-N C[C@@]1([C@@]2(C#N)O)OCC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c(C=C)c2C Chemical compound C[C@@]1([C@@]2(C#N)O)OCC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c(C=C)c2C BDHDDBGWWKEZPZ-GSIQFNFPSA-N 0.000 description 1
- DQAYZBDIJAYFBJ-NNKBYCLSSA-N C[C@@]1([C@H](C2)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 Chemical compound C[C@@]1([C@H](C2)O)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 DQAYZBDIJAYFBJ-NNKBYCLSSA-N 0.000 description 1
- HPAZRONRZMRAJY-IEBNOHBYSA-N C[C@@]1([C@H](CO)C2)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 Chemical compound C[C@@]1([C@H](CO)C2)OC2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 HPAZRONRZMRAJY-IEBNOHBYSA-N 0.000 description 1
- UIARLYUEJFELEN-YKQNXRHISA-N C[C@@]1([C@](CO)(C2)O)O[C@H]2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 Chemical compound C[C@@]1([C@](CO)(C2)O)O[C@H]2[n]2c3c4[n]1c1ccccc1c4c(CNC1=O)c1c3c1c2cccc1 UIARLYUEJFELEN-YKQNXRHISA-N 0.000 description 1
- HXGMCPSJILOUIU-DMVVYWCZSA-N C[C@](C1)([C@]2(C)OC1[n]1c3c4[n]2c2ccccc2c4c(CNC2=O)c2c3c2c1cccc2)O Chemical compound C[C@](C1)([C@]2(C)OC1[n]1c3c4[n]2c2ccccc2c4c(CNC2=O)c2c3c2c1cccc2)O HXGMCPSJILOUIU-DMVVYWCZSA-N 0.000 description 1
- JQLOBXMWLRSYBB-NKQHSMGESA-N C[C@]([C@](CO)(C1)O)([n]2c3c(c(CN4)c5C4=O)c4ccccc24)OC1Nc3c5-c1ccccc1C Chemical compound C[C@]([C@](CO)(C1)O)([n]2c3c(c(CN4)c5C4=O)c4ccccc24)OC1Nc3c5-c1ccccc1C JQLOBXMWLRSYBB-NKQHSMGESA-N 0.000 description 1
- LVNZNWPGOIAQBY-LROUJFHJSA-N C[C@]1([C@]2(C)OC[C@H]1[n]1c3c4[n]2c2ccccc2c4c(CNC2=O)c2c3c2c1cccc2)O Chemical compound C[C@]1([C@]2(C)OC[C@H]1[n]1c3c4[n]2c2ccccc2c4c(CNC2=O)c2c3c2c1cccc2)O LVNZNWPGOIAQBY-LROUJFHJSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60920304P | 2004-09-10 | 2004-09-10 | |
| US11/222,409 US20060058250A1 (en) | 2004-09-10 | 2005-09-08 | Methods of treating proliferative skin diseases using carbazole derivatives |
| PCT/US2005/032489 WO2006031772A1 (en) | 2004-09-10 | 2005-09-09 | Methods of treating proliferative skin diseases using carbazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008512497A JP2008512497A (ja) | 2008-04-24 |
| JP2008512497A5 true JP2008512497A5 (https=) | 2008-10-16 |
Family
ID=36034857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531441A Withdrawn JP2008512497A (ja) | 2004-09-10 | 2005-09-09 | カルバゾール誘導体を用いる増殖性皮膚疾病の処置方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060058250A1 (https=) |
| EP (1) | EP1786418A1 (https=) |
| JP (1) | JP2008512497A (https=) |
| KR (1) | KR20070113186A (https=) |
| AR (1) | AR050930A1 (https=) |
| AU (1) | AU2005285007A1 (https=) |
| BR (1) | BRPI0515115A (https=) |
| CA (1) | CA2577024A1 (https=) |
| IL (1) | IL181003A0 (https=) |
| MX (1) | MX2007002532A (https=) |
| MY (1) | MY156431A (https=) |
| NO (1) | NO20071052L (https=) |
| TW (1) | TW200621266A (https=) |
| WO (1) | WO2006031772A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR114110A1 (es) | 2018-02-28 | 2020-07-22 | Lilly Co Eli | Anticuerpo anti-trka |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| DK1044203T3 (da) * | 1997-12-31 | 2003-07-14 | Cephalon Inc | 3'-epimere K-252a-derivater |
| US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
| US6013646A (en) * | 1998-07-02 | 2000-01-11 | Bayer Corporation | Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| US6399780B1 (en) * | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
| EP1309721A2 (en) * | 2000-08-11 | 2003-05-14 | Cephalon, Inc. | Modulating multiple lineage kinase proteins |
| US6667173B2 (en) * | 2000-12-01 | 2003-12-23 | The Schepens Eye Research Institute | Nucleic acids encoding platelet derived growth factor-alpha receptors |
| US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
-
2005
- 2005-09-08 US US11/222,409 patent/US20060058250A1/en not_active Abandoned
- 2005-09-09 JP JP2007531441A patent/JP2008512497A/ja not_active Withdrawn
- 2005-09-09 AR ARP050103785A patent/AR050930A1/es unknown
- 2005-09-09 CA CA002577024A patent/CA2577024A1/en not_active Abandoned
- 2005-09-09 KR KR1020077008005A patent/KR20070113186A/ko not_active Withdrawn
- 2005-09-09 EP EP05796536A patent/EP1786418A1/en not_active Ceased
- 2005-09-09 AU AU2005285007A patent/AU2005285007A1/en not_active Abandoned
- 2005-09-09 MY MYPI20054257A patent/MY156431A/en unknown
- 2005-09-09 BR BRPI0515115-5A patent/BRPI0515115A/pt not_active IP Right Cessation
- 2005-09-09 WO PCT/US2005/032489 patent/WO2006031772A1/en not_active Ceased
- 2005-09-09 TW TW094131097A patent/TW200621266A/zh unknown
- 2005-09-09 MX MX2007002532A patent/MX2007002532A/es not_active Application Discontinuation
-
2007
- 2007-01-28 IL IL181003A patent/IL181003A0/en unknown
- 2007-02-23 NO NO20071052A patent/NO20071052L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516314A5 (https=) | ||
| US20030004142A1 (en) | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway | |
| JP2005507938A5 (https=) | ||
| JP2019510832A5 (https=) | ||
| JP2013507415A5 (https=) | ||
| JP2006528700A5 (https=) | ||
| JP2017504642A5 (https=) | ||
| JP2004514663A5 (https=) | ||
| CA2440037A1 (en) | Benzimidazole derivatives for modulating the rage receptor | |
| JP2009507896A5 (https=) | ||
| JP2010505865A5 (https=) | ||
| JP2012525393A5 (https=) | ||
| JP2017505314A5 (https=) | ||
| JP2021527125A5 (https=) | ||
| JPWO2020123827A5 (https=) | ||
| JP2006528701A5 (https=) | ||
| EP2275107A3 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| JP2014511891A5 (https=) | ||
| JP2003503385A5 (https=) | ||
| JP2009526865A5 (https=) | ||
| JP2004517843A5 (https=) | ||
| JP2007507494A5 (https=) | ||
| JP2004502732A5 (https=) | ||
| JP2004525140A5 (https=) | ||
| JP2010530002A5 (https=) |